Eli Lilly launches cheaper vial version of blockbuster weight-loss drug - Financial Times
- Eli Lilly launches cheaper vial version of blockbuster weight-loss drug Financial Times
- Lilly launches lower-price weight loss drug without injector pen CNN
- A Popular Weight Loss Drug Is Getting a Price Cut The New York Times
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Investors | Eli Lilly and Company
- Eli Lilly slashes Zepbound prices for self-pay patients Yahoo Finance